Khaled F. Massri-Al
Gaza, GZZ, Palestine
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Mesenchymal Stem Cells and Their Exosomes as Novel Modulators of Gut Microbiota: Therapeutic Perspectives for Liver Diseases and Inflammatory Bowel Disease.
Journal: Microbial pathogenesis
Published: February 22, 2026
Impact of co-morbidities on preconditioning signalling cascades in cardiovascular diseases: strategies for intervention.
Journal: European journal of pharmacology
Published: February 11, 2026
Insights into the role of gut microbiota modulation in the management of various cardiovascular diseases: A new approach for improving the efficacy of current cardiovascular medications.
Journal: European journal of pharmacology
Published: July 16, 2025
New Approaches for Enhancement of the Efficacy of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Diseases.
Journal: Tissue engineering and regenerative medicine
Published: April 07, 2022
Gut Microbiota Modulation for Therapeutic Management of Various Diseases: A New Perspective Using Stem Cell Therapy.
Journal: Current molecular pharmacology
Published: June 04, 2021
Mesenchymal stem cells in chemotherapy-induced peripheral neuropathy: A new challenging approach that requires further investigations.
Journal: Journal of tissue engineering and regenerative medicine
Published: April 28, 2019
Mesenchymal stem cells therapy enhances the efficacy of pregabalin and prevents its motor impairment in paclitaxel-induced neuropathy in rats: Role of Notch1 receptor and JAK/STAT signaling pathway.
Journal: Behavioural brain research
Published: October 07, 2018
Pregabalin and lacosamide ameliorate paclitaxel-induced peripheral neuropathy via inhibition of JAK/STAT signaling pathway and Notch-1 receptor.
Journal: Neurochemistry international
Published: May 18, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026